HomeMRNS • NASDAQ
add
Marinus Pharmaceuticals Inc
Previous close
$1.42
Day range
$1.38 - $1.46
Year range
$1.11 - $11.26
Market cap
78.00M USD
Avg Volume
3.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 7.19M | 0.39% |
Operating expense | 15.36M | 4.78% |
Net income | -41.77M | -21.73% |
Net profit margin | -580.93 | -21.26% |
Earnings per share | -0.81 | -6.24% |
EBITDA | -34.93M | -23.97% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 150.29M | -37.52% |
Total assets | 170.91M | -34.14% |
Total liabilities | 154.14M | 7.40% |
Total equity | 16.76M | — |
Shares outstanding | 54.64M | — |
Price to book | 4.58 | — |
Return on assets | -47.67% | — |
Return on capital | -61.01% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -41.77M | -21.73% |
Cash from operations | -26.99M | -23.17% |
Cash from investing | 6.47M | 8,084.81% |
Cash from financing | 661.00K | -99.30% |
Net change in cash | -19.86M | -127.48% |
Free cash flow | -10.28M | 33.39% |
About
Founded
2003
Headquarters
Website
Employees
166